Package 83257-010-11

{"route": ["INTRAVASCULAR"], "spl_id": "bd1edac2-0e84-e635-7bef-e167ba08ed0d", "openfda": {"nui": ["N0000193543", "N0000178291", "N0000193542"], "upc": ["0383257010115", "0383257009119"], "unii": ["2S9ZZM9Q9V"], "rxcui": ["2712048", "2712055", "2712057", "2712058"], "spl_set_id": ["70ab1de6-fb68-aee4-a6cb-f9a0f146687f"], "pharm_class_epc": ["Vascular Endothelial Growth Factor Inhibitor [EPC]"], "pharm_class_moa": ["Vascular Endothelial Growth Factor-directed Antibody Interactions [MoA]", "Vascular Endothelial Growth Factor Inhibitors [MoA]"], "manufacturer_name": ["Biocon Biologics Inc."], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "1 VIAL, SINGLE-DOSE in 1 CARTON (83257-010-11)  / 16 mL in 1 VIAL, SINGLE-DOSE", "package_ndc": "83257-010-11", "marketing_start_date": "20250410"}], "brand_name": "JOBEVNE", "product_id": "83257-010_bd1edac2-0e84-e635-7bef-e167ba08ed0d", "dosage_form": "INJECTION", "pharm_class": ["Vascular Endothelial Growth Factor Inhibitor [EPC]", "Vascular Endothelial Growth Factor Inhibitors [MoA]", "Vascular Endothelial Growth Factor-directed Antibody Interactions [MoA]"], "product_ndc": "83257-010", "generic_name": "bevacizumab-nwgd", "labeler_name": "Biocon Biologics Inc.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "JOBEVNE", "active_ingredients": [{"name": "BEVACIZUMAB", "strength": "25 mg/mL"}], "application_number": "BLA761175", "marketing_category": "BLA", "marketing_start_date": "20250410", "listing_expiration_date": "20261231"}